A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetes Mellitus, Type 2

In brief

The purpose of this study is to determine the safety and efficacy of albiglutide in subjects with type 2 diabetes

Key facts

Study ID

NCT00839527

Run by

GlaxoSmithKline

People needed

685

Starts

2009-02-01

Expected to finish

2013-04-01

Last updated by the study team

2017-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• type 2 diabetes
• BMI 20-45kg/m2 inclusive

You may not qualify if…

• females who are pregnant, lactating, or less than 6 weeks post-partum
• current symptomatic heart failure (NYHA Class II-IV)

Where it is running

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Dothan, Alabama, United States
• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Tuscaloosa, Alabama, United States
• GSK Investigational Site — Chandler, Arizona, United States
• GSK Investigational Site — Gilbert, Arizona, United States
• GSK Investigational Site — Green Valley, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Bull Shoals, Arkansas, United States
• GSK Investigational Site — Harrisburg, Arkansas, United States
• GSK Investigational Site — Hot Springs, Arkansas, United States
• GSK Investigational Site — Jonesboro, Arkansas, United States
• GSK Investigational Site — Searcy, Arkansas, United States
• GSK Investigational Site — Buena Park, California, United States
• GSK Investigational Site — Chino, California, United States
• GSK Investigational Site — Chula Vista, California, United States
• GSK Investigational Site — Alabaster, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.